Rens De Groot: New Proteomic Evidence Reveals Early Hemolysis During ADAMTS13 Relapse in Immune TTP
Rens De Groot, Principal Research Fellow at University College London, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Advances, adding:
”New paper in Blood Advances.
In immune TTP, we found haemolysis is already underway during an ADAMTS13 relapse – while patients are still clinically well and routine markers like platelet count and LDH look normal.
Using unbiased plasma proteomics across 24 iTTP patients, we saw a clear haemolysis signature whenever ADAMTS13 activity was low.
All reversible once ADAMTS13 recovered.
So a low ADAMTS13 isn’t just a risk marker — the pathways that drive acute TTP are already switched on. Should the threshold for pre-emptive rituximab be reconsidered?
Led by Tim Postmus and Pieter Langerhorst, with Maryam Subhan, Eva Smit, Jan Voorberg, Mari Thomas, Maartje van den Biggelaar, and Marie Scully, – a Sanquin / UCL, / University College London Hospitals NHS Foundation Trust collaboration.
Thanks to the UK TTP Registry and the patients who made it possible.”
Title: Unbiased plasma proteomics reveals hemolysis during ADAMTS13 relapse in patients with immune TTP.
Authors: Tim Postmus, Maryam Owais Subhan, Eva R Smit, Jan Voorberg, Mari Thomas, Maartje van den Biggelaar, Marie Scully, Rens de Groot, Pieter Langerhorst

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 11, 2026, 19:56Louise St. Germain Bannon: A Fantastic Start to ISTH 2026 and the Future of Thrombosis Research
-
Jul 11, 2026, 19:38Lynn Kloeckner: Recognizing Kirsten Lacine’s Impact on the Stroke Survivor Journey
-
Jul 11, 2026, 19:01Laurent Bertoletti: Honoring the Legacy of Guy Meyer and the INNOVTE Network at ISTH 2026
-
Jul 11, 2026, 18:53Pilar de la Rocha Mur: Why Trust Is the Most Valuable Currency in Clinical Research
-
Jul 11, 2026, 18:25First Pathogenic Deep-Intronic SERPINC1 Variant Identified in Hereditary Antithrombin Deficiency – JTH
-
Jul 11, 2026, 18:12Dianne E. van der Wal: A Thought-Provoking Discussion on Immunothrombosis at ISTH 2026
-
Jul 11, 2026, 16:07Louise St. Germain Bannon: Where Innovation Meets Collaboration at ISTH 2026
-
Jul 11, 2026, 15:22Cécile Denis: A Unique Opportunity for Emerging Hemostasis Leaders
-
Jul 11, 2026, 15:03Dino Mehic: Paris Welcomes the Global Hemostasis Community at ISTH 2026